rs6076347

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021067.5(GINS1):​c.289G>A​(p.Val97Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.43 in 1,598,772 control chromosomes in the GnomAD database, including 158,124 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V97V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.35 ( 10903 hom., cov: 32)
Exomes 𝑓: 0.44 ( 147221 hom. )

Consequence

GINS1
NM_021067.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.71

Publications

54 publications found
Variant links:
Genes affected
GINS1 (HGNC:28980): (GINS complex subunit 1) The yeast heterotetrameric GINS complex is made up of Sld5 (GINS4; MIM 610611), Psf1, Psf2 (GINS2; MIM 610609), and Psf3 (GINS3; MIM 610610). The formation of the GINS complex is essential for the initiation of DNA replication in yeast and Xenopus egg extracts (Ueno et al., 2005 [PubMed 16287864]).[supplied by OMIM, Mar 2008]
GINS1 Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to GINS1 deficiency
    Inheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.201003E-4).
BP6
Variant 20-25418154-G-A is Benign according to our data. Variant chr20-25418154-G-A is described in ClinVar as Benign. ClinVar VariationId is 1169882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.466 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GINS1NM_021067.5 linkc.289G>A p.Val97Ile missense_variant Exon 4 of 7 ENST00000262460.5 NP_066545.3 Q14691

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GINS1ENST00000262460.5 linkc.289G>A p.Val97Ile missense_variant Exon 4 of 7 1 NM_021067.5 ENSP00000262460.4 Q14691

Frequencies

GnomAD3 genomes
AF:
0.350
AC:
53136
AN:
151968
Hom.:
10898
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.154
Gnomad AMI
AF:
0.335
Gnomad AMR
AF:
0.381
Gnomad ASJ
AF:
0.484
Gnomad EAS
AF:
0.00885
Gnomad SAS
AF:
0.312
Gnomad FIN
AF:
0.424
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.471
Gnomad OTH
AF:
0.386
GnomAD2 exomes
AF:
0.382
AC:
95925
AN:
251376
AF XY:
0.389
show subpopulations
Gnomad AFR exome
AF:
0.144
Gnomad AMR exome
AF:
0.386
Gnomad ASJ exome
AF:
0.487
Gnomad EAS exome
AF:
0.00500
Gnomad FIN exome
AF:
0.425
Gnomad NFE exome
AF:
0.471
Gnomad OTH exome
AF:
0.426
GnomAD4 exome
AF:
0.439
AC:
634508
AN:
1446686
Hom.:
147221
Cov.:
28
AF XY:
0.437
AC XY:
315149
AN XY:
720662
show subpopulations
African (AFR)
AF:
0.142
AC:
4716
AN:
33298
American (AMR)
AF:
0.388
AC:
17364
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.491
AC:
12777
AN:
26040
East Asian (EAS)
AF:
0.00328
AC:
130
AN:
39676
South Asian (SAS)
AF:
0.328
AC:
28205
AN:
85972
European-Finnish (FIN)
AF:
0.425
AC:
22680
AN:
53354
Middle Eastern (MID)
AF:
0.450
AC:
2582
AN:
5734
European-Non Finnish (NFE)
AF:
0.475
AC:
521339
AN:
1098022
Other (OTH)
AF:
0.413
AC:
24715
AN:
59894
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
15524
31049
46573
62098
77622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14966
29932
44898
59864
74830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.349
AC:
53147
AN:
152086
Hom.:
10903
Cov.:
32
AF XY:
0.345
AC XY:
25626
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.154
AC:
6388
AN:
41484
American (AMR)
AF:
0.382
AC:
5827
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.484
AC:
1681
AN:
3472
East Asian (EAS)
AF:
0.00887
AC:
46
AN:
5188
South Asian (SAS)
AF:
0.313
AC:
1507
AN:
4820
European-Finnish (FIN)
AF:
0.424
AC:
4472
AN:
10556
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.471
AC:
32001
AN:
67980
Other (OTH)
AF:
0.384
AC:
810
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1612
3224
4836
6448
8060
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
500
1000
1500
2000
2500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.433
Hom.:
74132
Bravo
AF:
0.340
TwinsUK
AF:
0.478
AC:
1772
ALSPAC
AF:
0.485
AC:
1868
ESP6500AA
AF:
0.157
AC:
691
ESP6500EA
AF:
0.470
AC:
4039
ExAC
AF:
0.379
AC:
46020
Asia WGS
AF:
0.154
AC:
534
AN:
3478
EpiCase
AF:
0.483
EpiControl
AF:
0.486

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 65% of patients studied by a panel of primary immunodeficiencies. Number of patients: 62. Only high quality variants are reported. -

Combined immunodeficiency due to GINS1 deficiency Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
4.3
DANN
Benign
0.62
DEOGEN2
Benign
0.086
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.85
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.00082
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.77
N
PhyloP100
1.7
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.23
N
REVEL
Benign
0.054
Sift
Benign
1.0
T
Sift4G
Benign
0.94
T
Polyphen
0.0020
B
Vest4
0.056
MPC
0.21
ClinPred
0.0013
T
GERP RS
0.27
Varity_R
0.049
gMVP
0.39
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6076347; hg19: chr20-25398790; COSMIC: COSV52465262; COSMIC: COSV52465262; API